Long-term safety and efficacy of deutetrabenazine for the treatment of tardive dyskinesia

OBJECTIVE: To evaluate the long-term safety and efficacy of deutetrabenazine in patients with tardive dyskinesia (TD). METHOD: Patients with TD who completed the 12 week, phase 3, placebo-controlled trials were eligible to enter this open-label, single-arm study. The open-label study consisted of a...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Neurol Neurosurg Psychiatry
Главные авторы: Fernandez, Hubert H, Stamler, David, Davis, Mat D, Factor, Stewart A, Hauser, Robert A, Jimenez-Shahed, Joohi, Ondo, William G, Jarskog, L Fredrik, Woods, Scott W, Bega, Danny, LeDoux, Mark S, Shprecher, David R, Anderson, Karen E
Формат: Artigo
Язык:Inglês
Опубликовано: BMJ Publishing Group 2019
Предметы:
Movement Disorders
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6902058/
https://ncbi.nlm.nih.gov/pubmed/31296586
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jnnp-2018-319918
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы